КЛИНИЧЕСКИЙ И ЭХОКАРДИОГРАФИЧЕСКИЙ АНАЛИЗ СПОНГИОФОРМНОЙ КАРДИОМИОПАТИИ ПРИ ОШИБОЧНОМ ДИАГНОЗЕ И ПРИ ОТСУТСТВИИ ДИАГНОЗА
https://doi.org/10.15829/1560-4071-2014-7-eng-34-41
Аннотация
Цель. Эхокардиография стала основным средством в обнаружении спонгиоформной кардиомиопатии (NCC). Однако, ошибочный диагноз и отсутствие диагноза, были повсеместными. Целью данной работы является анализ случаев ошибочного диагноза и отсутствия диагноза NCC, чтобы улучшить точность диагностики этого заболевания.
Материал и методы. Мы ретроспективно проанализировали данные 56 пациентов, которые были клинически диагностированы с NCC в нашем учреждении, в исследование были включены полные данные эхокардиографические пациентов с момента начала заболевания. Эхокардиографические данные и данные сердечной магнитно-резонансного исследования (CMR) сравнивались друг с другом.
Результаты. 17-ти пациентам была диагностирована NCC после первого эхокардиографического исследования в нашем учреждении. 39 пациентов не были диагностированы правильно до тех пор, пока несколько раз небыли проверены эхокардиографически. 28-ми из них была ошибочно диагностирована дилатационная кардиомиопатия (DCM) в местных больницах. Все данные, кроме 2-х пациентов, были совмещены между результатами эхокардиографии и CMR. Соотношение N/C 2,63±0,49 было при CMR, и 2,55±0,43 при эхокардиографии.
Заключение. Эхокардиография может быть первым выбором при NCC для оценки, вследствие следующих преимуществ: нерадиационный режим реального времени, экономические затраты и характеристика. Когда эхокардиографическое изображение не является типичным в ранней стадии NCC, то сочетание с CMR необходимо.
Об авторах
Yanna Liu
Department of Ultrasonics, the Second Affiliated Hospital of Nanchang University
Китай
Китай
Professor (M.D.),
No. 1, Minde Road, Nanchang, China. Postal code: 330006
Qinghua Wu
Department of Cardiology, the Second Affiliated Hospital of Nanchang
University
Китай
Nanchang
Китай
Nanchang
Список литературы
1. Peters F, Khandheria BK, Santos CD, et al. Isolated left ventricular noncompaction in subSaharan Africa: a clinical and echocardiographic perspective. Circ Cardiovasc Imaging 2012; 5 (2): 187–93.
2. Paterick TE, Tajik AJ. Left Ventricular Noncompaction — A Diagnostically Challenging Cardiomyopathy. Circ J 2012; 76 (7): 1556–62.
3. Andres ER, Ricardo BV, Luigi GN, et al. Noncompaction cardiomyopathy: a series of 15 cases. Rev Med Chile 2011; 139 (7): 864–71.
4. Bhatia NL, Tajik AJ, Wilansky S, et al. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail 2011; 17 (9): 771–8.
5. Rosa LV, Salemi VMC, Alexandre LM, Mady C. Noncompaction Cardiomyopathy a Current View. Arq Bras Cardiol 2011; 97 (1): e13–9.
6. Yang HJ, Song BG, Ma BO, et al. A rare combination of left ventricular noncompaction, patent ductus arteriosus, and persistent left superior vena cava demonstrated by multidetector computed tomography and echocardiography. Heart Lung 2012; 41 (6): e35-e8.
7. Mipinda JB, Ibaba J, Nkoghe DD, Kombila PA. Family form of isolated left ventricular noncompaction; case of a mother and her son observed in Gabon. Ann Cardiol Angeiol 2013; 62 (1): 56–9.
8. Stollberger C, Blazek G, Wegner C, Finsterer J. Heart failure, atrial fibrillation and neuromuscular disorders influence mortality in left ventricular hypertrabeculation/ noncompaction. Cardiology 2011; 119 (3): 176–82.
9. Steffel J, Hurlimann D, Namdar M, et al. Long-term follow-up of patients with isolated left ventricular noncompaction: role of electrocardiography in predicting poor outcome. Circ J 2011; 75 (7): 1728–34.
10. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18 (12): 1440–63.
11. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A Statement for Healthcare Professionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105 (4): 539–42.
12. Frischknecht BS, Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr 2005; 18 (8): 865–72.
13. Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/ noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90 (8): 899–902.
14. Boyd MT, Seward JB, Tajik AJ, Edwards WD. Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol 1987; 9 (2): 323–26.
15. Kohli SK, Pantazis AA, Shah JS et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008; 29 (1): 89–95.
16. Arun R, Gnanavelu G, Venkatesan S, et al. Isolated noncompaction of right ventricle— a case report. Echocardiography 2012; 29 (7): 169–72.
17. Song ZZ. A possible diagnosis of isolated right ventricular hypertrabeculation / noncompaction in an elderly man by three-dimensional echocardiography. Int J Cardiol 2011; 147 (1): 4–7.
18. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005; 46 (1): 101–5.
19. Penela D, Bijnens B, Doltra A, et al. Noncompaction Cardiomyopathy is Associated With Mechanical Dyssynchrony: A Potential Underlying Mechanism for Favorable Response to Cardiac Resynchronization Therapy. J Card Fail 2013; 19 (2): 80–86.
20. Grothoff M, Pachowsky M, Hoffmann J, et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol 2012; 22 (12): 2699–709.
21. Xi Y, Ai T, De Lange E, et al. Loss of function of hNav1.5 by a ZASP1 mutation associated with intraventricular conduction disturbances in left ventricular noncompaction. Circ Arrhythm Electrophysiol 2012; 5 (5): 1017–26.
22. Chang B, Gorbea C, Lezin G, et al. 14–3–3epsilon gene variants in a Japanese patient with left ventricular noncompaction and hypoplasia of the corpus callosum. Gene 2013; 515 (1): 173–80.
23. Moric-Janiszewska E, Markiewicz-Loskot G. Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy. Clin Cardiol 2008; 31 (5): 201–4.
24. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol 2009; 30 (5): 625–81.
25. Alizadeh-Sani Z, Madadi S, Sadeghpour A, et al. Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy. J Tehran Heart Cent 2011; 6 (4): 214–16.
26. Frischkneeht BS, Attenhofer Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Sec Echocardiogr 2005; 18 (8): 865–72.
27. Holmström M, Kivistö S, Heliö T, et al. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy. J Cardiovasc Magn Reson 2011; 13: 30.
28. Hoedemaekers YM, Caliskan K, Michels M, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 2010; 3 (3): 232–9.
29. Duncan RF, Brown MA, Worthley SG. Increasing Identification of Isolated Left Ventricular Non-Compaction with Cardiovascular Magnetic Resonance: A Mini Case Series Highlighting Variable Clinical Presentation. Heart Lung Circ 2008; 17 (1): 9–13.
30. Cheng H, Zhao S, Jiang S, et al. Cardiac magnetic resonance imaging characteristics of isolated left ventricular noncompaction in a Chinese adult Han population. Int J Cardiovasc Imaging 2011; 27 (7): 979–87.
31. Calvillo P, Marti-Bonmatl L, Chaustre F, et al. MRI quantification of myocardial function, perfusion, and enhancement in patients with left-ventricular noncompaction. Radiologia 2009; 51 (1): 45–56.
32. Ahmed AA, Syed I, Seward JB, Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging 2008; 27 (3): 621–4.
33. Junqueira FP, Fernandes FD, Coutinho AC, et al. Case report. Isolated left ventricular myocardium non-compaction: MR imaging findings from three cases. Br J Radiol 2009; 82 (974): e37-e41.
34. Eitel I, Fuernau G, Walther C, et al. Delayed enhancement magnetic resonance imaging in isolated noncompaction of ventricular myocardium. Clin Res Cardiol 2008; 97 (4): 277–9.
35. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002; 47 (2): 372–83.
36. Zhao L, Ma X, DeLano MC, et al. Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 2013; 23 (4): 1034–43.
Рецензия
Для цитирования:
Liu Ya., Wu Q. КЛИНИЧЕСКИЙ И ЭХОКАРДИОГРАФИЧЕСКИЙ АНАЛИЗ СПОНГИОФОРМНОЙ КАРДИОМИОПАТИИ ПРИ ОШИБОЧНОМ ДИАГНОЗЕ И ПРИ ОТСУТСТВИИ ДИАГНОЗА. Российский кардиологический журнал. 2014;(7-eng):34-41. https://doi.org/10.15829/1560-4071-2014-7-eng-34-41
For citation:
Liu Ya., Wu Q. THE CLINICAL AND ECHOCARDIOGRAPHIC ANALYSIS OF NONCOMPACTION CARDIOMYOPATHY IN MISDIAGNOSIS AND MISSED DIAGNOSIS. Russian Journal of Cardiology. 2014;(7-eng):34-41. https://doi.org/10.15829/1560-4071-2014-7-eng-34-41
Просмотров: 712
Послать статью по эл. почте 